Breaking news
Abbott beats Nycomed and UCB in battle for Solvay’s drug unit
Abbott Laboratories will buy Solvay’s pharmaceutical unit for €4.8bn ($7bn) according to reports released earlier today.
Archives for September 27, 2009
WHO endorses African clinical trial registry
The Pan-African Clinical Trials Registry (PACTR) has become the first such database to be endorsed by the WHO, providing the world with access to studies on the continent and improving efficiencies.
West opens its first manufacturing site in China
West has opened its first manufacturing facility in China to meet rising demand but the process has taken since 2006 and been “very tedious”, its president of West Asia Pacific told Outsourcing-Pharma.
A new president of Eli Lilly USA and a resignation over disagreements at Caraco – People on the move
in-PharmaTechnologist presents its latest round up of appointments in the pharma sector, including a new president of Eli Lilly USA and a resignation over disagreements at Caraco.
Bankrupt Introgen reborn as CMO
Having filed for bankruptcy in December Introgen Therapeutics has sold its assets, including management and technical team, to Vivante, a company that formed last week as a contract manufacturing organisation (CMO).
Health Decisions hopes Management View will cut monitoring costs
US CRO Health Decision says the new “Monitor View” module for its HD360 trial management system makes assessing study site performance an easier and more cost effective process.
Almac unveils Portadown expansion plan
Northern Ireland-based contract services firm Almac has been cleared to expand its HQ in Portadown, creating up to 500 new jobs.
Nycomed plans €75m Russian plant; may up €4.5bn bid for Solvay
Late last week Swiss drugmaker Solvay confirmed its plan to invest up to $75m (€51m) to build a new manufacturing plant in Yaroslavl, Russia.